Wang L, Lin J, Liu S, Cao S, Liu J, Yong Q, Yang Y, Wu B, Pan X, Du L, Wu C, Qin Y, Chen B
Department of Atherosclerosis, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Affiliated of Capital University of Medical Sciences, Beijing 100029, PR China.
Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):391-400. doi: 10.1016/j.numecd.2008.07.011. Epub 2008 Dec 13.
Familial hypercholesterolemia (FH) is an autosomal dominant disorder of lipoprotein metabolism caused by mutations in the low-density lipoprotein receptor (LDL-R) gene, leading to elevated levels of cholesterol and an increased risk of coronary heart disease. In this article, from four homozygous FH phenotype probands we identified disease causing mutations and analyzed the relationship between genotype and phenotype.
DNA sequencing identified five LDL-R point mutations in four unrelated families. We found a novel homozygous mutation (C210R), a homozygous mutation at W462X, a compound heterozygous mutation of C122Y and T383I, and a G>A intron 3 splice site homozygous mutation. The functional alteration caused by the novel C210R mutation was confirmed by FACS analysis. Four probands have high low-density lipoprotein cholesterol (LDL-C) levels, ranging from 14.65 to 27.66 mmol/L. Their heterozygous parents had relatively low levels. B-mode ultrasound supplemented by Doppler was used to examine aortic/mitral valve structural alterations and carotid intima-media thickness (ITM) in all probands. The ITM values were between 1.2 and 2.3mm, much higher than the normal value of <0.8mm.
Our data demonstrated that all the probands were associated with severe hypercholesterolemia, thick carotid IMT and a low CFVR (coronary flow velocity reserve) value. The novel mutation (C120Y) is a disease causing mutation.
家族性高胆固醇血症(FH)是一种常染色体显性脂蛋白代谢紊乱疾病,由低密度脂蛋白受体(LDL-R)基因突变引起,导致胆固醇水平升高及冠心病风险增加。在本文中,我们从4例纯合子FH表型先证者中鉴定出致病突变,并分析了基因型与表型之间的关系。
DNA测序在4个无亲缘关系的家族中鉴定出5个LDL-R点突变。我们发现了一个新的纯合突变(C210R)、一个W462X纯合突变、一个C122Y和T383I的复合杂合突变以及一个G>A内含子3剪接位点纯合突变。通过FACS分析证实了新的C210R突变引起的功能改变。4例先证者的低密度脂蛋白胆固醇(LDL-C)水平较高,范围为14.65至27.66 mmol/L。他们的杂合子父母水平相对较低。采用B超加多普勒检查所有先证者的主动脉/二尖瓣结构改变及颈动脉内膜中层厚度(ITM)。ITM值在1.2至2.3mm之间,远高于<0.8mm的正常值。
我们的数据表明,所有先证者均与严重高胆固醇血症、颈动脉内膜中层厚度增加及低冠状动脉血流速度储备(CFVR)值相关。新突变(C